Xuzhang Lu Selected Research

5-(6)-carboxyfluorescein diacetate succinimidyl ester (CFSE)

4/2019	Rapamycin downregulates NKG2D ligands in acute myeloid leukemia cells via an activation of the STAT3 pathway: a potential mechanism for rapamycin-induced immune escape in leukemia.
1/2015	Matrine regulates immune functions to inhibit the proliferation of leukemic cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xuzhang Lu Research Topics

Disease

12	Leukemia 01/2022 - 10/2004
6	Aplastic Anemia (Anemia, Hypoplastic) 12/2010 - 10/2004
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2021 - 01/2015
5	Neoplasms (Cancer) 09/2021 - 01/2015
4	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 12/2010 - 10/2004
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2015 - 03/2010
2	Multiple Myeloma 01/2018 - 10/2016
2	Myeloid Leukemia (Leukemia, Myelocytic) 03/2010 - 03/2007
1	Trisomy (Trisomies) 04/2022
1	Lymphoma (Lymphomas) 09/2021
1	Lung Neoplasms (Lung Cancer) 05/2017
1	Chromosome Aberrations (Chromosome Abnormalities) 10/2016
1	Abnormal Karyotype 10/2016
1	Graft vs Host Disease (Graft-Versus-Host Disease) 02/2011
1	Bone Marrow Failure Disorders 01/2009
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2004

Drug/Important Bio-Agent (IBA)

6	LigandsIBA 04/2019 - 03/2010
5	AntibodiesIBA 12/2010 - 10/2004
4	MatrinesIBA 12/2017 - 01/2015
4	moesinIBA 12/2010 - 03/2007
3	micaIBA 05/2017 - 03/2010
3	Proteins (Proteins, Gene)FDA Link 12/2010 - 10/2004
2	5-(6)-carboxyfluorescein diacetate succinimidyl ester (CFSE)IBA 04/2019 - 01/2015
2	NK Cell Lectin-Like Receptor Subfamily KIBA 05/2017 - 01/2015
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2011 - 12/2010
2	AutoantibodiesIBA 12/2010 - 03/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2009 - 01/2009
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 04/2022
1	Lysine (L-Lysine)FDA Link 01/2022
1	MethyltransferasesIBA 01/2022
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 12/2021
1	Gemcitabine FDA Link 09/2021
1	ThymalfasinIBA 09/2021
1	Core Binding Factors (Core-Binding Factor)IBA 07/2019
1	TOR Serine-Threonine KinasesIBA 04/2019
1	Sirolimus (Rapamycin)FDA Link 04/2019
1	nuclear pore complex protein 98IBA 03/2019
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 03/2019
1	Proteasome InhibitorsIBA 01/2018
1	CytokinesIBA 05/2017
1	Tartrate-Resistant Acid PhosphataseIBA 10/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2016
1	Biological ProductsIBA 01/2015
1	Phosphotransferases (Kinase)IBA 01/2015
1	AlkaloidsIBA 01/2015
1	Decitabine FDA Link 01/2015
1	Interleukin-6 (Interleukin 6)IBA 01/2015
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2015
1	Tacrolimus (Prograf)FDA LinkGeneric 02/2011
1	Methotrexate (Mexate)FDA LinkGeneric 02/2011
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 02/2011
1	Immunosuppressive Agents (Immunosuppressants)IBA 02/2011
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 12/2010
1	Heterogeneous-Nuclear Ribonucleoprotein KIBA 12/2010
1	Valproic Acid (Depakote)FDA LinkGeneric 03/2010
1	Hydroxyurea (Hydrea)FDA LinkGeneric 03/2010
1	DNA (Deoxyribonucleic Acid)IBA 09/2008
1	ThymineIBA 09/2008
1	ImmunosorbentsIBA 10/2004
1	AntigensIBA 10/2004
1	AutoantigensIBA 10/2004
1	EnzymesIBA 10/2004
1	Diazepam Binding InhibitorIBA 10/2004

Therapy/Procedure

1	Therapeutics 01/2018
1	Immunotherapy 01/2015
1	Stem Cell Transplantation 09/2008